Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells.
Carlo-Stella
Carmelo
C
University of Milano, Istituto Nazionale Tumori, Department of Medical Oncology, Milano, Italy. carmelo.carlostella@unimi.it
Lavazza
Cristiana
C
Carbone
Antonino
A
Gianni
Alessandro M
AM
D000256:Adenoviridae / Q000378:metabolism; D000818:Animals; D018952:Antigens, CD34 / Q000096:biosynthesis*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008495:Medical Oncology / Q000379:methods; D008954:Models, Biological; D013234:Stem Cells / Q000166:cytology* / Q000378:metabolism; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000096:biosynthesis*
D018952:Antigens, CD34; D000970:Antineoplastic Agents; D053221:TNF-Related Apoptosis-Inducing Ligand